These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28135789)

  • 1. [Second Korean Guideline for the Management of Ulcerative Colitis].
    Choi CH; Moon W; Kim YS; Kim ES; Lee BI; Jung Y; Yoon YS; Lee H; Park DI; Han DS;
    Korean J Gastroenterol; 2017 Jan; 69(1):1-28. PubMed ID: 28135789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guidelines for the management of ulcerative colitis].
    Choi CH; Kim YH; Kim YS; Ye BD; Lee KM; Lee BI; Jung SA; Kim WH; Lee H;
    Korean J Gastroenterol; 2012 Feb; 59(2):118-40. PubMed ID: 22387836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second Korean guidelines for the management of ulcerative colitis.
    Choi CH; Moon W; Kim YS; Kim ES; Lee BI; Jung Y; Yoon YS; Lee H; Park DI; Han DS;
    Intest Res; 2017 Jan; 15(1):7-37. PubMed ID: 28239313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
    Lakatos L; Lakatos PL
    Orv Hetil; 2007 Jun; 148(25):1163-70. PubMed ID: 17573252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern use of 5-aminosalicylic acid compounds for ulcerative colitis.
    Le Berre C; Roda G; Nedeljkovic Protic M; Danese S; Peyrin-Biroulet L
    Expert Opin Biol Ther; 2020 Apr; 20(4):363-378. PubMed ID: 31498003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Second Korean Guidelines for the Management of Crohn's Disease].
    Park JJ; Yang SK; Ye BD; Kim JW; Park DI; Yoon H; Im JP; Lee KM; Yoon SN; Lee H;
    Korean J Gastroenterol; 2017 Jan; 69(1):29-54. PubMed ID: 28135790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of ulcerative colitis.
    Blonski W; Buchner AM; Lichtenstein GR
    Curr Opin Gastroenterol; 2014 Jan; 30(1):84-96. PubMed ID: 24285003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical treatment and management of severe ulcerative colitis.
    Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ulcerative Colitis.
    Sonnenberg E; Siegmund B
    Digestion; 2016; 94(4):181-185. PubMed ID: 27931025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
    Eliadou E; Day AS; Thompson-Fawcett MW; Gearry RB; Rowbotham DS; Walmsley R; Schultz M; Inns SJ; ;
    N Z Med J; 2015 Oct; 128(1423):63-76. PubMed ID: 26645757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of Treatment Guidelines for Ulcerative Colitis: Role of Biologics].
    Bae JH; Yang DH
    Korean J Gastroenterol; 2018 Apr; 71(4):192-195. PubMed ID: 29684967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry study.
    Hyams JS; Lerer T; Mack D; Bousvaros A; Griffiths A; Rosh J; Otley A; Evans J; Stephens M; Kay M; Keljo D; Pfefferkorn M; Saeed S; Crandall W; Michail S; Kappelman MD; Grossman A; Samson C; Sudel B; Oliva-Hemker M; Leleiko N; Markowitz J;
    Am J Gastroenterol; 2011 May; 106(5):981-7. PubMed ID: 21224840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsule-endoscopic findings of ulcerative colitis patients.
    Higurashi T; Endo H; Yoneda M; Hosono K; Sakai E; Takahashi H; Inamori M; Uchiyama S; Kojima T; Kawana K; Natsumeda Y; Nagase H; Nakajima A
    Digestion; 2011; 84(4):306-14. PubMed ID: 22041924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild-to-Moderate Ulcerative Colitis Guideline.
    Cross R; Ko CW; Singh S
    Gastroenterology; 2019 Feb; 156(3):768. PubMed ID: 30684447
    [No Abstract]   [Full Text] [Related]  

  • 17. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Hibi T; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):85-95; quiz e14-5. PubMed ID: 23735746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional medical management of inflammatory bowel disease.
    Burger D; Travis S
    Gastroenterology; 2011 May; 140(6):1827-1837.e2. PubMed ID: 21530749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.
    Busquets D; Aldeguer X
    J Crohns Colitis; 2013 Jun; 7(5):e195. PubMed ID: 23219261
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients.
    Protic M; Seibold F; Schoepfer A; Radojicic Z; Juillerat P; Bojic D; Mwinyi J; Mottet C; Jojic N; Beglinger C; Vavricka S; Rogler G; Frei P
    J Crohns Colitis; 2014 Nov; 8(11):1427-37. PubMed ID: 24908178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.